Research and Development (R&D) Expenses: R&D expenses decreased to $5.8 million for the three months ended March 31, 2025, ...

The FDA has accepted the new drug application for the antipsychotic Bysanti and set a goal date for February 21, 2026.

The product, available in 200 mg, 400 mg, 600 mg, and 800 mg strengths, is the generic equivalent of Sumitomo Pharma ...

In a precedential decision issued May 6, 2025, the Federal Circuit reversed in part and vacated in part a Delaware district ...

The FDA has communicated to Stealth BioTherapeutics that it would not meet elamipretide’s PDUFA target date for the treatment of Barth syndrome.

An advocate for cancer patients has said that patients will "die waiting" for cancer treatments in Ireland after a study ...

Merck & Co.‘s planned debut this fall of an injectable form of its breakthrough cancer treatment Keytruda will simplify care, ...

There are 21 applicants to become the city of New Bedford’s next chief of police. Here's the process of what happens next.

A former reality television contestant facing drug trafficking charges will be staying in custody for the rest of this week ...

Dengue fever now threatens half of the world’s population, but small molecule treatments could be an answer to treating the .

Announced U.S. Food and Drug Administration (FDA) approval of VYKAT XR (diazoxide choline) extended-release tablets, ...

The new bosses of a run-down pub say troublemakers will be barred - amid neighbours’ fears of fighting, drugs and “screaming ...